Citadel Advisors »

Chemomab Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Chemomab Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chemomab Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemomab Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $171k 104k 1.65

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Chemomab Therapeutics

Citadel Advisors
ADAR1 Capital Management
Kestra Private Wealth Services
Ikarian Capital
XTX Topco
Rhumbline Advisers
Jane Street
SmartHarvest Portfolios
Virtu Financial
Bnp Paribas Arbitrage, Snc
GAMMA Investing
UBS Group
SBI Securities
Northwestern Mutual Wealth Management Company

View all funds holding Chemomab Therapeutics